3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
12
Neoplasms
11
Brain Neoplasms
10
Lung Neoplasms
9
Glioma
9
Glioblastoma
9
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Colorectal Neoplasms
5
Rectal Neoplasms
4
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Multiple Myeloma
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Anus Neoplasms
3
Urinary Bladder Neoplasms
2
Thyroid Cancer, Papillary
2
Small Cell Lung Carcinoma
2
Recurrence
2
Oligodendroglioma
2
Neurotoxicity Syndromes
2
Neuroendocrine Tumors
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Interventions
Blood Specimen Collection
6
Surveys and Questionnaires
5
Observation
3
Colonoscopy
3
Biopsy
3
Remote Patient Monitoring
2
Nivolumab
2
Interviews as Topic
2
Gastroscopy
2
trastuzumab deruxtecan
1
s-formylglutathione hydrolase
1
lutetium Lu 177 dotatate
1
copper dotatate CU-64
1
Videotape Recording
1
Validation Studies as Topic
1
Ultrasonography
1
Tomography, X-Ray Computed
1
Standard of Care
1
Specimen Handling
1
Single-Balloon Enteroscopy
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy
1
Quality of Life
1
Proctectomy
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Lutetium-177
1
Lutetium
1
Induction Chemotherapy
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Gastrointestinal Neoplasms
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT01816607
2018-11-19
OxyTarget
University Hospital, Akershus
Completed
192 enrolled